< Back to previous page

Project

Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe) (SRP48)

Anti-tumor vaccination requires the identification of target antigens on resistant tumor subpopulations, adequate immune competence of the patients and the availability of efficient vaccination techniques.
Date:1 Nov 2017 →  Today
Keywords:Dendritic Cells, Tonic Pain, Evoked Potentials, Bispecific Antibodies, Immunotherapy, Immunology, Oncology
Disciplines:Cancer therapy